Nivolumab/pembrolizumabTuberculosis: 2 case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1742卷 / 1期

关键词：

D O I：

10.1007/s40278-019-58634-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：176 / 176

相关论文

共 50 条

[41] Nivolumab/pazopanibHepatotoxicity and fatigue: case report
Reactions Weekly, 2019, 1777 (1) : 183 - 183
[42] Nivolumab/pazopanibVarious toxicities: case report
Reactions Weekly, 2022, 1887 (1) : 533 - 533
[43] Nivolumab/prednisoneVarious toxicities: case report
Reactions Weekly, 2021, 1861 (1) : 256 - 256
[44] Nivolumab/prednisoloneVarious toxicities: case report
Reactions Weekly, 2019, 1752 (1) : 299 - 299
[45] Nivolumab/oxaliplatinVarious toxicities : case report
Reactions Weekly, 2024, 2017 (1) : 393 - 393
[46] Nivolumab/sunitinibVarious toxicities: case report
Reactions Weekly, 2022, 1905 (1) : 402 - 402
[47] Nivolumab/pazopanibLack of efficacy: case report
Reactions Weekly, 2022, 1898 (1) : 311 - 311
[48] Atorvastatin/nivolumabMyositis (first report with nivolumab): case report
Reactions Weekly, 2015, 1577 (1) : 49 - 49
[49] Case report: a case of Panhypopituitarism secondary to ipilimumab and nivolumab
Dunne, R. M.
Lyons, R.
Divilly, P.
O'Shea, D.
Crown, J.
Crowley, R. K.
IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 : S225 - S225
[50] Lithium/nivolumab/prednisoneVarious toxicities: case report
Reactions Weekly, 2020, 1829 (1) : 237 - 237

← 1 2 3 4 5 →